Ki-67在肝细胞癌并微血管癌栓中表达的意义
Significance of Ki-67 Expression in Hepatocellular Carcinoma with Microvascular Tumor Thrombus
DOI: 10.12677/ACM.2021.116360, PDF,   
作者: 徐翔宇, 刘 奎, 李 坤, 刘 鹏, 解宇威, 高瑞谦, 王 晶, 仲灏辰, 艾宪程, 曹景玉*:青岛大学附属医院,山东 青岛
关键词: 肝细胞癌Ki-67MVIHepatocellular Carcinoma Ki-67 MVI
摘要: 目的:探讨Ki-67在肝细胞癌微血管侵犯(微血管侵犯:MVI)中表达的意义。方法:对青岛大学附属医院从2013年1月到2020年6月进行的约680例行根治性肝切除手术并确诊为肝细胞癌的患者的临床及病理资料进行回顾性分析。结果:这680例患者中,MVI阳性的患者占53.2% (362/680)。通过单因素分析,发现MVI的发生与Ki-67阳性有关,此外还有患者的年龄、性别、饮酒史、术前白蛋白、甲胎蛋白(AFP)、癌抗原125 (CA125)、谷草转氨酶(AST)、γ-谷氨酰转肽酶、肿瘤最大直径、肿瘤数目、是否存在卫星结节与MVI的发生有关(均P < 0.05)。多因素Logistic回归分析结果显示:Ki-67是MVI的独立危险因素。MVI的其他独立危险因素还包括AST、性别,肿瘤直径 > 3 cm,存在卫星结节(均P < 0.05)。结论:Ki-67的高表达(≥20%)与MVI的发生有关。
Abstract: Objective: To investigate the significance of Ki-67 expression in microvascular invasion (MVI) of HCC. Methods: The clinical and pathological data of 680 patients with liver cancer diagnosed as HCC were analyzed retrospectively from January 2013 to June 2020 in the Affiliated Hospital of Qingdao University. Results: Among the 680 patients, 53.2% (362/680) of the patients were with MVI positive. The results showed that MVI was related to Ki-67 positive by single factor analysis. In addition, the age, sex, drinking history, preoperative albumin, AFP, CA125, AST, and the age of the patients, γ-glutamyl transpeptidase, the largest diameter of tumor, the number of tumors and the presence of satellite nodules were also observed related to the occurrence of MVI (P < 0.05). The results of multivariate logistic regression analysis showed that Ki-67 was an independent risk factor for MVI. Other independent risk factors of MVI included AST, sex, tumor diameter > 3 cm, satellite nodule (P < 0.05). Conclusion: The high expression of Ki-67 (≥20%) is associated with MVI.
文章引用:徐翔宇, 刘奎, 李坤, 刘鹏, 解宇威, 高瑞谦, 王晶, 仲灏辰, 艾宪程, 曹景玉. Ki-67在肝细胞癌并微血管癌栓中表达的意义[J]. 临床医学进展, 2021, 11(6): 2507-2513. https://doi.org/10.12677/ACM.2021.116360

参考文献

[1] Shi, Q., et al. (2020) SSH3 Promotes Malignant Progression of HCC by Activating FGF1-Mediated FGF/FGFR Pathway. European Review for Medical and Pharmacological Sciences, 24, 11561-11568.
[2] Ziogas, I. and Tsoulfas, G. (2017) Advances and Challenges in Laparoscopic Surgery in the Management of Hepatocellular Carcinoma. World Journal of Gastrointestinal Surgery, 9, 233-245. [Google Scholar] [CrossRef] [PubMed]
[3] Zeng, H., et al. (2018) Changing Cancer Survival in China during 2003-15: A Pooled Analysis of 17 Population-Based Cancer Registries. The Lancet Global Health, 6, e555-e567. [Google Scholar] [CrossRef
[4] Huang, Z., et al. (2012) Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in China. Annals of Surgical Oncology, 19, 2515-2525. [Google Scholar] [CrossRef] [PubMed]
[5] Neumann, U. (2011) Outcome after Partial Hepatectomy for Hepatocellular Cancer within the Milan Criteria. The British Journal of Surgery, 98, 1300-1301. [Google Scholar] [CrossRef] [PubMed]
[6] Yang, J., et al. (2019) A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management. Nature Reviews. Gastroenterology & Hepatology, 16, 589-604. [Google Scholar] [CrossRef] [PubMed]
[7] Gerdes, J., et al. (1983) Production of a Mouse Monoclonal Antibody Reactive with a Human Nuclear Antigen Associated with Cell Proliferation. International Journal of Cancer, 31, 13-20. [Google Scholar] [CrossRef] [PubMed]
[8] 廖谦和, 等. 子宫颈癌及癌前病变HPV16、Ki-67的表达及其相关性[J]. 临床与实验病理学杂志, 2007(3): 297-299.
[9] 原发性肝癌诊疗规范(2019年版) [J]. 中国临床医学, 2020, 27(1): 140-160.
[10] 吴孟超, 等. 原发性肝癌规范化病理诊断指南(2015年版) [J]. 临床肝胆病杂志, 2015, 31(6): 833-839.
[11] 何旭昶, 等. 微血管侵犯分级对肝细胞癌行根治性肝切除术后早期复发的预测价值[J]. 临床肝胆病杂志, 2020, 36(8): 1757-1762.
[12] 李彦龙, 张媛, 王逢茂. 术前CT征象对孤立性肝癌微血管侵犯及术后早期复发的预测分析[J]. 中国CT和MRI杂志, 2021, 19(1): 113-116.
[13] 夏勇, 杨田, 王葵. 肝细胞癌肝切除术后复发预防和治疗中国专家共识(2020版) [J]. 中国实用外科杂志, 2021, 41(1): 20-30.
[14] Lim, M., et al. (2011) Predictable Factors for Lymph Node Metastasis in Early Gastric Cancer-Analysis of Single Institutional Experience. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract, 15, 1783-1788. [Google Scholar] [CrossRef] [PubMed]
[15] 崔凯, 张利平. p16蛋白、Ki67抗原检测在宫颈上皮内瘤变中的诊断价值[J]. 检验医学与临床, 2019, 16(24): 3704-3706.
[16] 贺红梅, 等. IMP3、P16、HE4、Ki67、P53在卵巢浆液性肿瘤中表达的生物学意义、鉴别诊断及预后的研究[J]. 临床和实验医学杂志, 2020, 19(23): 2537-2540.
[17] 李文华, 张莹. 乳腺癌复发转移灶与原发灶中ER、PR、HER-2、p53、Ki-67的表达差异[J]. 临床与实验病理学杂志, 2016, 32(7): 727-730.
[18] 齐兴峰, 等. 食管癌组织中Ki-67和VEGF的表达及其与放疗预后的关系[J]. 临床合理用药杂志, 2019, 12(34): 44-46+48.
[19] 王娜, 等. NEDD9、Ki67、P53联合检测对胃癌的早期诊断和恶性程度评估的价值[J]. 实用医学杂志, 2017, 33(12): 1961-1965.
[20] 贾磊, 等. CD34和Ki67的表达预测肝癌术后复发的风险[J]. 肝脏, 2020, 25(2): 197-199.
[21] 王凝芳, 等. Ki-67在肝细胞肝癌中的表达及其临床意义[J]. 大连大学学报, 2003(2): 71-73+79.
[22] 孙树刚, 等. 肝细胞癌E-cadherin和ki-67蛋白表达与肝切除术预后关系的研究[J]. 中国现代普通外科进展, 2010, 13(2): 125-128.
[23] 张景丽, 等. 乳腺癌Ki-67及PCNA表达的比较研究[J]. 临床与实验病理学杂志, 2003(1): 70-72.
[24] Imamura, H., et al. (2003) Risk Factors Contributing to Early and Late Phase Intrahepatic Recurrence of Hepatocellular Carcinoma after Hepatectomy. Journal of Hepatology, 38, 200-207. [Google Scholar] [CrossRef